Find your path to Brad
211 people in our graph share verified history with Brad — schools, employers, funds. One of them is your warm intro.
Hal PazunlockedBrad: together at Johnson & Johnson (2005–2007)
×10Brad: together at Johnson & Johnson
Brad: together at Columbia University Vagelos College of Physicians and Surgeons
About
Brad Navia is a neurologist and physician-scientist serving as Fractional Chief Medical Officer at Solaxa, with prior CMO roles from 2021 to 2025 at Aprinoia and Therini, both focused on Alzheimer's disease. His industry career includes positions at Johnson & Johnson, Eisai, AbbVie, and Sunovion, where he led the Kynmobi program for Parkinson's disease that received FDA and EMA approval; across his work he has overseen more than 20 clinical trials spanning Phases 1 through 3 in neurology and psychiatry. Earlier in his career he held academic appointments at Harvard Medical School and Massachusetts General Hospital, Tufts University School of Medicine, Boston University, and Brown University, and holds a PhD in neuroscience and genetics.
Chief Medical Officer at Solaxa
Intro paths
→
In turn, Brad can intro founders to Solaxa's investors below.
Solaxa's investors · 2
Co-founders at Solaxa
MN
Mark NobleChief Science Officer & Co-Founder
Experience
- SolaxaFractional Chief Medical Officercurrent2026 — presentNorth America
- AlumisSenior Consultantcurrent2026 — present
- Next CNS Solutions, LLCFoundercurrent2026 — present
- Sinopia BiosciencesChief Medical Advisor (Consultant CMO)current2026 — present
- Sinopia BiosciencesSenior Consultant2025Boston, Massachusetts, United States
- PAR ClinicalBoard Membercurrent2025 — presentUnited States
- PAR ClinicalStrategic Advisor2025 — 2026
- Therini Bio, Inc.Chief Medical Officer2024 — 2025Sacramento, California, United States
- APRINOIA TherapeuticsChief Medical Officer2021 — 2024Cambridge, Massachusetts, United States
- Sunovion PharmaceuticalsExecutive Director2014 — 2021Marlborough, Massachusetts, United States
- Eisai USSenior Director, Head of Imaging2010 — 2013Woodcliff Lake, New Jersey, United States
- Tufts University Medical SchoolAssociate Professor1997 — 2013Boston, Massachusetts, United States
- Johnson & JohnsonDirector, CNS, Pain and Clinical Development2005 — 2009Titusville, New Jersey, United States
Skills & more
NeuroimagingClinical Development1Leadership1Drug Development2Interpersonal Skills1Executive Visibility1Strategic Leadership6Team Leadership9Clinical Research13Neuroscience20Genetics11Clinical Trials19
+4 more
Clinical Neurology, Translat.Medicine, biomarkers (imaging, genetics), Drug Dev,Internal Medicine, Neurovirology, Neuroimmunology, ImagingNeurologyTranslational MedicineFrom Brad's professional profile.
Frequently asked questions
- Who is Brad Navia?
- Brad Navia is a neurologist and physician-scientist serving as Fractional Chief Medical Officer at Solaxa, with prior CMO roles from 2021 to 2025 at Aprinoia and Therini, both focused on Alzheimer's disease. His industry career includes positions at Johnson & Johnson, Eisai, AbbVie, and Sunovion, where he led the Kynmobi program for Parkinson's disease that received FDA and EMA approval; across his work he has overseen more than 20 clinical trials spanning Phases 1 through 3 in neurology and psychiatry. Earlier in his career he held academic appointments at Harvard Medical School and Massachusetts General Hospital, Tufts University School of Medicine, Boston University, and Brown University, and holds a PhD in neuroscience and genetics.
- Where does Brad Navia work?
- Brad Navia is Chief Medical Officer at Solaxa.
- Where did Brad Navia go to school?
- Brad Navia studied at Harvard University (Doctor of Philosophy (PhD), Neuroscience and Genetics); Columbia University Vagelos College of Physicians and Surgeons (MD); Columbia University (BA).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Columbia University Vagelos College of Physicians and Surgeons33
Tristan HuntPartner at Averin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesShreeram AradhyeInvestor at Novartis Venture FundJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundCurt LaBelleVenture Partner at Adjuvant Capital
+ 27 more
Also attended Columbia University1,302
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 1,296 more
Shared employers
Also worked at Solaxa2
Also worked at Therini Bio, Inc.6
Kazufumi NakamuraInvestment Director at Mitsui Global InvestmentAlex Badamchi-ZadehVice President at SV Health InvestorsPeter DudekPresident at MRL Ventures FundRobin MansukhaniCEO and Co-Founder at Deciduous TherapeuticsTara NickersonExecutive Officer, Director at Therini BioKaterina AkassoglouScientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes at Therini Bio
Also worked at APRINOIA Therapeutics1
Also worked at Sunovion Pharmaceuticals15
Kaitlyn LagascaManager, Talent Acquisition at Anzu PartnersDario DollerCo-founder at Modulate BioFred GrossmanExecutive Officer at Coya TherapeuticsAntony LoebelExecutive Officer at Seaport TherapeuticsJohn CrowleyExecutive Officer at MerusCurtis LockshinExecutive Officer at Xenetic Biosciences
+ 9 more